All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CORDYCEPS SUNSHINE BIOTECH HOLDINGS CO., LTD. Last Reported: 9/30/2023 Stock Symbol: NONE

Business Address

6TH FL., NO. 15, LANE 548
RUIGUANG ROAD, NEIHU DISTRICT
TAIPEI CITY , TW 00000

Mailing Address

6TH FL., NO. 15, LANE 548
RUIGUANG ROAD, NEIHU DISTRICT
TAIPEI CITY , TW 00000
Phone Number: 886-2-27489091 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 12/31/2022 9/30/2022 12/31/2021 7/31/2021 12/31/2020 7/31/2020
Cash and Cash Equivalents $16,911.00 $16,100.00 -- $99,684.00 -- $294.00 --
Accounts Receivable Net Current -- $149,510.00 -- $358,006.00 -- -- --
Inventory $4,308.00 $313,530.00 -- $480,352.00 -- $685,410.00 --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- --
Total Current Assets $52,135.00 $501,552.00 -- $1,130,828.00 -- $949,007.00 --
Property Plant and Equipement $1,545,203.00 $1,425,135.00 -- $1,713,954.00 -- $1,712,162.00 --
Intangible Assets Net -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- --
Total Assets $1,797,722.00 $2,104,853.00 -- $3,263,038.00 -- $2,825,711.00 --
Accounts Payable -- $751,135.00 -- $111,696.00 -- $123.00 --
Accrued Liabilities -- $62,754.00 -- $56,407.00 -- $29,529.00 --
Total Current Liabilities $1,980,661.00 $3,056,187.00 -- $3,538,851.00 -- $2,838,523.00 --
Long Term Debt -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $62,151.00 $40,841.00 -- $-3,731.00 -- $664.00 --
Accumulated Deficit $-477,490.00 $-1,224,575.00 -- $-504,482.00 -- $-13,476.00 --
Total Stockholders' Equity $-182,939.00 $-951,334.00 $117,086.00 $-275,813.00 -- $-12,812.00 --
Controlling Interest in Subsidiaries -- -- -- -- -- -- --
Total Liabilities and Equity $1,797,722.00 $2,104,853.00 -- $3,263,038.00 -- $2,825,711.00 --

Statement of Operations

Date 9/30/2023 12/31/2022 9/30/2022 12/31/2021 7/31/2021 12/31/2020 7/31/2020
Total Revenues $567,031.00 $448,785.00 -- $879,318.00 -- $134,720.00 --
Cost of Revenues $85,304.00 $515,457.00 -- $1,055,530.00 -- $40,648.00 --
Gross Profit $481,727.00 $-66,672.00 -- $-176,212.00 -- $94,072.00 --
Research and Development -- $118,444.00 -- $25,052.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- --
Total Operating Expenses $374,342.00 $576,030.00 $378,220.00 $300,968.00 -- $85,340.00 --
Loss from Operations $107,385.00 $-642,702.00 $-378,220.00 $-477,180.00 -- $8,732.00 --
Loss Before Income Taxes $107,385.00 -- $-378,220.00 -- -- -- --
Earnings Per Share Basic -- $-0.01 $-0.01 -- -- -- --
Weighted Average Shares Basic 111,120,000 104,417,534 100,000,000 100,000,000 -- 100,000,000 --
Earnings Per Share Diluted -- $-0.01 $-0.01 -- -- -- --
Weighted Average Shares Diluted 111,120,000 104,417,534 100,000,000 100,000,000 -- 100,000,000 --
Common Stock Shares Authorized 500,000,000 500,000,000 -- 500,000,000 -- 500,000,000 --
Common Stock Shares Outstanding 111,120,000 111,120,000 -- 111,120,000 -- 111,120,000 --
Common Stock Value $11,112.00 $11,112.00 -- $10,000.00 -- $10,000.00 --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 -- $0.00 $0.02 $0.00 $0.00
Payments Of Dividends Common Stock -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- --
Copyright 2024 PursePoor.com